ArticleJAMA oncology2021

Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.

Salma K Jabbour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.